Loading clinical trials...
Loading clinical trials...
A Phase II Study of Treatment De-Escalation for Favorable Prognosis, Stage I-II Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy
Conditions
Interventions
Radiation
Locations
2
United States
Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
Medstar Southern Maryland Hospital Center
Clinton, Maryland, United States
Start Date
August 1, 2019
Primary Completion Date
December 31, 2028
Completion Date
December 31, 2030
Last Updated
April 17, 2026
NCT06532279
NCT07209189
NCT06563479
NCT07065630
NCT04988074
NCT07044635
Lead Sponsor
Georgetown University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions